The Senior Management team at Reneo Pharmaceuticals is responsible for setting the strategic direction and overseeing the execution of the company's initiatives focused on developing therapies for genetic mitochondrial diseases. This team, comprised of directors and top executives, collaborates to ensure effective operational management, financial oversight, and regulatory compliance, while fostering innovation and driving the company's clinical programs forward. Their collective leadership guides Reneo in achieving its mission to improve patient outcomes through groundbreaking therapies.
View all